Finerenone Slows Kidney Decline in Non-Diabetic CKD Patients

Chronic kidney disease (CKD) is a condition where the kidneys can't filter waste from the blood well.

While diabetes is a common cause, many people get CKD from other reasons like high blood pressure.

Until now, treatment options for non-diabetic CKD patients were limited, leaving them at risk of needing dialysis or a kidney transplant.

A new study found that a pill called finerenone can help slow down kidney damage in these patients.

Finerenone works by blocking a hormone that causes inflammation and scarring in the kidneys.

The study showed that people taking finerenone had slower kidney function decline and less protein in their urine, which is a sign of kidney damage.

This means their kidneys stayed healthier for longer.

The drug is not a cure, but it can help keep kidneys working better and reduce serious complications.

However, finerenone can have side effects, like increasing blood potassium levels, so patients need regular blood tests.

Doctors say this new treatment could be a big help for non-diabetic CKD patients, giving them more options to keep their kidneys healthy.